http://hayinkerala.blogspot.com/2010/12/day-2-bob-geldof-in-conversation-with.html
Thoughts on our only delicate and fragile planet. Biodiversity, Climate Change, Deforestation, forests, Forest degradation, Environment, Nature, Sustainable development, sustainable living. This blog is published by and reflects the personal views of Sarah Stephen. Please read the disclaimer at the bottom of the page.
Monday, December 20, 2010
Political activism
http://hayinkerala.blogspot.com/2010/12/day-2-bob-geldof-in-conversation-with.html
Thursday, December 9, 2010
Poll result: What MOST bothers you about the effect of lead ammunitions on fauna and humans?
No responses to the options of 'Lead poisoning in humans who ingest hunted game animals', 'Lead ammunitions do not cause any such effects. Ergo, this is all hogwash', and 'This issue is irrelevant and of no concern to me'.
Kissing the mistletoe goodbye?
The parasitic European Mistletoe, Viscum album, thrives on fruit

Mistletoe has a degree of ecological importance for it is an ecological keystone species (Watson, 2001). Since the plant provides food (especially during winter) and habitat for wildlife, it could be considered as having a positive effect on biodiversity.
The plant is also believed to have medicinal properties: lowering blood pressure and heart rate, easing anxiety, relieving headaches, improving concentration ability, and in the treatment of cancer (Ernst et al, 2003). In Germany, more than US $30 million is spent on mistletoe extracts, with a yearly sales increase of 20%.
Mistletoe’s anti-cancer properties remain a bone of contention (Ernst et al, 2003; Horneber et al, 2008). For instance, there are positive results (such as Hajto et al demonstrating that mistletoe’s ß-Galactoside-specific Lectin activated monocytes in the peripheral human blood, resulting in the secretion of Tumor Necrosis Factor a, Interleukin 1, and Interleukin 6, all of which can inhibit tumour growth; or, Büssing et al’s results which suggests that it could be used in the treatment of lymphoma and lymphocytic leukemia due to its property of inducing apoptosis in human lymphocytes), as well as negative (Steuer-Vogt et al, 2001; Gabius et al 2001). An exhaustive review of all randomised clinical trials (Ernst et al, 2003) illustrated that the published work had failed to demonstrate the efficacy of this therapy in cancer patients –in fact, it even had the potential to cause harm (as seen in Gabius et al’s study in which clinically relevant low doses of mistletoe lectin where shown to stimulate tumour proliferation in cell lines and histotypic cultures). Furthermore, there are grave concerns since lectins tend to sediment the erythrocytes.
Reverting to the gist of this post, our mango trees (here in Trivandrum, Kerala) have mistletoes (Loranthus sp) as well. And despite the unwelcome visitor’s virtues, we tend to care more about the potential mangoes, and hence excise the sprigs- and never fail to admire its tenacity when it springs back to life. In any case, due to the lack of a market for mistletoes in the country, there isn't any utility in retaining/cultivating these except during the Advent tradition of hanging up the mistletoe (and are probably a minority in following this tradition in the region). Ergo, I would to like to know the stance of the ‘traditional orchard’ owners. And, admittedly, during my years in Oxbridge (+London), I've noticed far more mistletoe in other trees than in apple.
Nonetheless, one does hope that the National Trust’s information on the mistletoe’s impending doom in the UK isn’t a case of crying wolf. Or is it indeed a legitimate concern?
Photo credit: sumeja
References:
http://www.nationaltrust.org.uk/main/w-global/w-news/w-latest_news/w-news-campaign-launched-to-give-mistletoe-the-kiss-of-life.htm
Horneber MA, Bueschel G, Huber R, Linde K, & Rostock M (2008). Mistletoe therapy in oncology. Cochrane database of systematic reviews (Online) (2) PMID: 18425885
Ernst E, Schmidt K, & Steuer-Vogt MK (2003). Mistletoe for cancer? A systematic review of randomised clinical trials. International journal of cancer. Journal international du cancer, 107 (2), 262-7 PMID: 12949804
Gabius HJ, Darro F, Remmelink M, André S, Kopitz J, Danguy A, Gabius S, Salmon I, & Kiss R (2001). Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts. Cancer investigation, 19 (2), 114-26 PMID: 11296616
Steuer-Vogt MK, Bonkowsky V, Ambrosch P, Scholz M, Neiss A, Strutz J, Hennig M, Lenarz T, & Arnold W (2001). The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. European journal of cancer (Oxford, England : 1990), 37 (1), 23-31 PMID: 11165126
Watson, DM (2001), Mistletoe-A Keystone Resource in Forests and Woodlands Worldwide, Annual Review of Ecology and Systematics 32, pp.219-249.
http://www.annualreviews.org/doi/abs/10.1146/annurev.ecolsys.32.081501.114024
Büssing A, Suzart K, Bergmann J, Pfüller U, Schietzel M, & Schweizer K (1996). Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer letters, 99 (1), 59-72 PMID: 8564930
Hajto, T., Hostanska, K., Frei, K., Rordorf, C., and H-J Gabius (1990). Increased Secretion of Tumor Necrosis Factor a, Interleukin 1, and Interleukin 6 by Human Mononuclear Cells Exposed to ß-Galactoside-specific Lectin from Clinically Applied Mistletoe Extract1. Cancer Res 50, pp. 3322
Labels:
apple,
cancer,
Christmas,
clinical trials,
hawthorn,
lime,
local,
mistletoe,
National Trust,
Natural England,
orchards,
parasite,
poplar,
sustainable,
tradition,
tumour,
UK,
US,
Viscum album
Subscribe to:
Posts (Atom)